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IN THE SUPREME COURT OF THE STATE OF UTAH 
LARRY RAY REEVES, * 
Plaintiff-Appellant, * 
v. * 
GEIGY PHARMACEUTICAL, INC., * Case No. 860409 
a division of CIBA-GEIGY 
CORPORATION, a New York 
Corporation; ELI LILLY & 
COMPANY, an Indiana corpora- * 
tion;, and GERALD R. MORESS, 
M. D. , • * 
Defendants-Respondents -
APPELLANT'b KLPL* LJKILF 
Appe 11 ant Larry Ray Reeves , 1: • > and through counse 1 , 
hereby submits the following Reply Brief in response to Respon-
dents' Br i e £ On Appeal. 
LN'i IWL^JCT 1L;N 
The contrast between the "Statement of Facts" containe'i in 
the Appellant Reeves' briefs ^^ i trie brief if K^sooridents, 
il n ;* - . - - :io. < -i -i ^ -- - - * which should 
not have been resdvea : v tne granting -if Respondents' Motions For 
Summary Judament on all of Appellant Reeves' claims against them 
by th - . .. . ..it. 
For example, Appellant Larry Reeves specifically contests 
Respondents' assertion that there was no evidence before the lower 
court to support Appellant Reeves' claim that the blistering skin 
disease he suffered was caused by the drugs Tegretol and/or Pheno-
barbital, manufactured and distributed to him by Respondents Moress, 
Geigy Pharmaceutical and Eli Lilly & Company. (Respondents' Br., 
para. 24, p.7, pp.8-11.) 
Appellant Reeves also specifically opposes Respondents' 
assertion that there was no evidence before the lower court 
indicating a genuine factual dispute on the issues of whether 
Respondent Moress was liable to Appellant as a "merchant", on 
the basis of strict product liability in tort, or breach of express 
or implied warranties, or was liable to Appellant Reeves for "medical 
malpractice", including his failure to obtain the "informed consent" 
of Larry Reeves, or his parent, to his treatment with the drugs 
Tegretol and/or Phenobarbital, as required pursuant to state statute. 
(Respondents' Br., Paras. 19, 24, pp.6-7, 11) 
Appellant Reeves will show that there were genuinely disputed 
material facts concerning each of the foregoing issues which 
rendered the grant of summary judgment thereon inappropriate, or 
that the evidence before the Court viewed in the light most 
favorable to Appellant Reeves as the party opposing summary 
judgment, did not entitle Respondents to such relief as a 
matter of law. Geneva Pipe Co. v. S & H Ins. Co., 714 P.2d 
648 (Utah 1986). 
Appellant Reeves also disputes Respondents' mischaracteriza-
tion of certain proceedings herein in relation to Appellant's 
2 
opposition to Respondents' Motions For Summary Judgment, 
including the following statements which appear in Respondents' 
"Staterr.'-Vi*.. — Facts": 
i-. **..Each defendant responded fully and completely 
tv ; the discovery requests made by the plaintiff. 
(Respondents' Br., p.5) 
As Appellant, h^s oreviousty indicates, and, as t-he recori 
refl ects, R ••-". -, :• * , ^y ,._-; \ : i: . . -1 .; i i < " u." 
refusaJ s t:u ODjectior.s :o ;.r.e orovision of .iccumenis and m:or-
ma*: ion which no' '~nl\ v-*-au:red Appellor!*:'-, counsel *:o sper : •.---
also require Appellant to conuucr. discovery from independent 
sources, nici ^ i : ~;- * l^  u.o. Food <* Drug Adminiscrr-t : ?r.. irvriicai 
periodicals an.i xoa^: i. experts, which discovery Appellant Reeves 
was pursuinc jt. -.he *:,.-_> Respondents fiLei :nt.r Motions For Summary 
uudgmer- - • ' i-"Vt--, * of Facts", pp » 4 • i ») 
Appellant _.x3w .; ,. jpui.-^  b IKOC'.JL1; *, ^  /.a :oment that: 
..e 4- -1.e the de f end ar. ts fi.ei their mot ions 
for summary judgment, the plaintiff had no out-
standing discovery demands. 
(Respondents' Br., p.6) 
Appellant Reeves disputes this statement in thai it. seeks 
' • - - - * •- :" i . - - . " - ' > s ; • - - . • - ,-.: :" ^ . . ' : . ' -- • - ' • - ^ - T - ' J - ; . - n 
further discovery, or t.nnt there was :.u rui'iher discovery tc he 
done, at the time Respondents filed their Motions For Summary 
Judgment. 
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As Appellant Reeves indicated in his "Statement of Facts", 
Appellant was still pursuing discovery through sources indepen-
dent of Respondents, and Appellant's counsel filed an Affidavit 
under Rule 56(f), U.R.C.P., verifying the need for further discovery 
to oppose Respondents' Motions for Summary Judgment and to prepare 
Appellant's case for trial, and anticipated that the lower court 
would permit further discovery given the complex nature of the 
case. (Appellant's Opening Br., "Statement of Facts", pp. 5-8) 
Appellant Reeves also contests Respondents' statements 
that the hearing on their Motions for Summary Judgment was 
postponed until June 2, 1986, "pursuant to plaintiff's motion 
and affidavit" (Respondents' Br., "Statement of Facts", Nos. 
22 and 23, p.7), in so far as Respondents suggest that the hearing 
was continued to provide Appellant Reeves the opportunity 
to file expert affidavits to oppose those filed by Respondents 
in support of their Motions for Summary Judgment. 
As counsel's Affidavit shows, the hearing on Respondents' 
Motion For Summary Judgment was scheduled on a date when 
Appellant's counsel was previously scheduled to be present for 
hearings in other courts, and was simply postoned to a non-
conflicting date. (Affidavit of Kathryn Collard, R. 189, paras, 
pp. 4-5) 
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ARGUMENT 
POINT I. THE EVIDENCE BEFORE ThE LOWER COURT PRESENTED 
A GENUINE FACTUAL DISPUTE CONCERNING THE 
CAUSE OF APPELLANT REEVES' INJURIES RENDERING 
SUMMARY JUDGMENT FOR RESPONDENTS ON THIS 
ISSUE IMPROPER. 
R e s p o n d e i 11 s , a s s e r t: i o i i t h a t Ap p e 1 1 a i 11 R e e v e s " c I a i m 
that the drugs Tegretol and/or Phenobarbital caused his injuries 
"remained completely unsupported" "after two v^irs of discovery" 
(Respoi ldents' Br. 8 ) , is incorrect, and blatanr../ ignores evidence of 
record in th is actio n. 
Contrary to Respondents1 erroneous assertion that the 
depositions of Or, Zone, '>. Piepkorn and Dr. Vvarde.* ' c DITIC. a tei / 
failed to substantiate" Appellant Reeves' claim thai his lt;sf.e:ing 
s k i n d . --.^ :<** A.-J •=; * t - • - - • . ^ -• J.- - ^- i - • - - j. : ." , 
(Respondents ,_, . , . ' .^r depositions L ^r . o^en Aarden, 
Larry Reeves i; :rv. .:. n/s IC-LCIM, -I:\C L.. Jose; • . -,:.-., 
' . _
 : ~ • - : . - T • 1 
a n d / o r r h e n c c aL-;i 11 a i , ..: in^f ^ t i. ..< -?d itc d i s t r i b u t e ! i : L a r r y k a e v e s 
L*y r e s p o n d e n t s , 'A-ar- '-* :i;r:-:
 ; \ o l ; . <--JUS^ o f h i s i n j u r i e s . 
I r ; - . . - . ' • - , : -. • . s • : : : g 
that .nt precise etio..o\ imechanise of action >r 1. *rry Keeves 
ciistermg skin disease is unknown, lestified l hat this disease 
" - " " A * n_.n.*i . ,vr"i, • t - .^ .. . .c. .. ^r^bcriptioi i and 
non-prescription drugs. 
b 
For example, Dr. Glen Warden, Larry Reeves' treating 
physician, testified that his blistering skin disease 
(It) has been related to medications, it's 
been related to viral injuries, it's been 
related to over-the-counter preparations; 
however the etiology remains unknown. 
(Warden Depo., pp.12-13) (Emphasis supplied) 
Dr. Warden also testified in his deposition that because 
of the known association between certain medications and the 
type of blistering skin disease suffered by Larry Reeves, he ordered 
Larry Reeves' medication with Tegretol and Phenobarbital to 
be discontinued, suggesting that Dr. Warden believed these 
drugs to be the cause of Larry Reeves' injury: 
Q. What was the purpose of the consultation with 
neurology? 
A. The patient has had a seizure disorder for many 
years and has been given a difficult—and continues 
to be difficult to control in his seizures; and because 
the patient was on seizure medication and they have been 
described to be an association with this disease, then 
we needed consultation from neurology to alter his 
medication for his seizure disorder. We did not want 
to continue him on the same medication. 
(Warden Depo., p.26) (Emphasis supplied) 
Dr. Warden further testified in his deposition that he 
had written a report on April 5, 1982, in which he stated that 
the etiology of Appellant Reeves' injuries "is probably due to 
Tegretol or phenobarbital." (Warden Depo., p.47) 
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Dr. Zone, a consulting physician on Larry Reeves' case, 
testified in his deposition that blistering skin disease of the type 
suffered by Larry Reeves is associated with the administration of 
medications and other substances. 
Reading from his initial diagnosis of Larry Reeves on 
November 2, 1981, Dr. Zone testified as follows 
Q: When you saw Larry the first time on November 2, 
you made an assessment. 
A: Yes. 
Q: What does an assessment mean? 
A: That means my opinion of the diagnosis at that 
point. 
Q: And why don't you just read that whole thing into 
the record, if you would, please, kind of slowly. 
A: "Toxic epidermal necrolysis is most likely diagnosis 
given the patient's medication. This has occurred 
with virtually any drug, virus infection, lympho-
mas and immunization. The shower history seems inad-
equate to cause a thermal injury. The patient is 
old for staphyloccal scalded skin syndrome and this 
is usually more painful, shortlived and more super-
ficial involvement. The lack of mucosal involvement 
and the presence of dermal injury are unusual for 
TEN but not unheard of." 
(Zone Depo., pp.18-19) (Emphasis supplied) 
Dr. Zone further testified that a history of drug exposure 
is a common clinical feature of toxic epidermal necrolysis (TEN), 
the diagnosis Dr. Zone gave to Larry Reeves' blistering skin disease: 
Q: Well typically, I'm just asking for the clinical 
features of TEN, how is it first manifest, how 
does it progress? 
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A: Basically what I said. Usually we get a history of 
either a viral illness, some type of new drug 
exposure, or repeat drug exposure, then it starts 
in small areas of blisters. 
(Zone Depo., p.20, lines 19-25) (Emphasis supplied) 
Dr. Zone further testified in his deposition, he could 
not rule out the possibility in Larry Reeves' case, that a 
dramatic increase in the dosage of not only one medication, 
but two medications that he was taking, could have precipitated 
"this kind of immune reaction." (Zone Depo., pp.47-48) 
Dr. Piepkorn, a physician whose only involvement with 
Larry Reeves, was that he performed a histological examination 
of a section of tissue from his body, testified that the tissue 
he examined showed extensive damaged to the dermis, the layer of 
skin below the epidermis, as well as damage to the epidermis. 
(Piepkorn Depo., pp.6-7,15) 
Dr. Piepkorn disagreed with Dr. Zone that damage to the 
dermis layer of the skin was consistent with a diagnosis of 
Toxic Epidermal Necrolysis (Zone Depo., p.19), because of Dr. 
Piepkorn1s view that, by definition, damage to the dermis places 
the injury outside the diagnosis of toxic epidermal necrolysis, 
which is typically concerned with damage to the epidermal layer 
of the skin. (Piepkorn Depo., pp.16, 22) 
Dr. Piepkorn testified that he wasn't aware of any 
drug induced cases of blistering skin disease similar to 
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that suffered by Larry Reeves which resulted in damage 
to the dermis layer of the skin, but stated that he has 
only personally seen two clinical cases of Toxic Epidermal 
Necrolysis. (Piepkorn Depo., pp.18, 22-23) 
By contrast, Dr. Zone testified that he had seen three 
or four cases which he had diagnosed as Toxic Epidermal Necro-
lysis involving extensive damage to the dermis as occurred in 
the case of Larry Reeves at the University Medical Center during 
the past six years. Dr. Zone stated that as far as he 
knew, none of these cases were reported in the medical liter-
ature. (Zone Depo., p.29) 
Respondents also falsely represent that the Affidavit of 
Dr. Joel A. Thompson "fully refuted the plaintiff's allegation that 
Tegretol and Phenobarbital somehow caused his skin disorder...", 
(Respondents' Br., 9). However, Dr. Thompson's Affidavit contains 
no opinion regarding the cause of Larry Reeves' injuries, 
only the statement that Dr. Thompson is not aware of any test 
that would have predicted a "cutaneous reaction to Tegretol." 
(Affidavit of Joel A. Thompson, M.D., para. 7, R. 162-164). 
The Affidavit of Respondents' expert, Dr. Leonard Swinyer, 
(R. 158-160) indicates that Dr. Swinyer is a physician special-
izing in dermatology, but does not indicate that he possesses 
any experience or expertise in the diagnosis of blistering skin 
diseases. 
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Dr. Swinyer states that he disagrees with the diagnosis of 
Larry Reeves' blistering skin disease as Toxic Epidermal Necroly-
sis made by his treating physicians, Dr. Warden and Dr. Zone, 
although his Affidavit does not indicate that he was provided 
or reviewed the depositions of Dr. Zone and Dr. Warden in forming 
this opinion. (R. 158-160) 
Dr. Swinyer does testify in his Affidavit that, in his 
opinion, "the medications given to Mr. Reeves by Dr. Moress 
were not the cause of Mr. Reeves' skin disorder, whatever the 
dissorders are diagnosed to be."( R. 160) However, this opinion 
is not expressed "to a reasonable medical certainty." (R. 160, 
para. 8) 
Thus, an objective analysis of the medical testimony before 
the lower court indicates, at most, that Larry Reeves' treating 
physicians and one of Respondents' medical experts disagreed 
as to whether Larry Reeves' blistering skin disease, whatever 
the proper technical diagnosis, was caused by Tegretol and/or 
Phenobarbital. 
Under these circumstances, Appellant Larry Reeves was 
entitled to have the disputed facts and expert medical opinions 
concerning the cause of his blistering skin disease submitted to 
the jury, even in the absence of any Affidavits filed by Appellant 
Reeves in opposition to the lone Affidavit of Dr. Swinyer, since 
10 
the sworn deposition testimony of Drs. Warden and Zone compels 
the conclusion that there was considerable evidence to support 
Appellant Reeves' claim that his injuries were caused by the drugs 
Tegretol and/or Phenobarbital. 
POINT II. THE TRIAL COURT ERRED IN GRANTING SUMMMARY 
JUDGMENT FOR RESPONDENT DR. MORESS ON 
APPELLANT REEVES' CLAIMS AGAINST HIM 
AS A "MERCHANT", BASED ON STRICT PRODUCTS 
LIABILITY IN TORT AND BREACH OF EXPRESS 
AND IMPLIED WARRANTIES. 
Respondent Dr. Moress premised his Motion for Summary Judg-
ment on the contentions that Appellant Reeves' case against him 
was a "medical malpractice action" and that in such action "it 
is plaintiff's burden to establish, by expert medical testimony, 
both the defendant/physician's standard of care, and that his 
care failed to conform to this standard." (R. 175-176; 169-171) 
Respondent Moress' assertion that this action involves 
only causes of action for "medical malpractice" against him, 
blindly ignores the First, Second, Third and Fourth Causes of Action 
alleged in Appellant's Complaint. (R. 3-12) 
In the First Cause of Action in his Complaint, Appellant 
Reeves seeks to impose liability against Dr. Moress as a "merchant" 
of the drugs Tegretol and/or Phenobarbital, under a theory of 
strict products liability in tort. (R. 3-8) 
In his Second, Third And Forth Causes of Action, Appellant 
Reeves seeks to impose liability against Dr. Moress as a 
11 
"merchant", for breach of implied and/or express warranties. 
(R. 8-12) 
in his Fifth, Sixth and Seventh Causes of Action, Appellant 
Reeves seeks to impose liability against Respondent Dr. Moress 
as a "physician" for "medical malpractice", including Dr. Moress' 
failure to obtain Appellant Reeves1 "informed consent" to be 
administered the drugs Tegretol and Phenobarbital for the 
treatment of his seizure disorder. (R. 12-20) 
Respondent Moress presented no evidence in the lower court 
to support the granting of summary judgment in his favor on 
Appellant Reeves1 First through Fourth Causes of Action against 
him as a "merchant." Rather, the Memorandum and Affidavits 
supporting Repondent Moress' Motion For Summary Judgment focused 
solely on Appellant Reeves' "medical malpractice" claims against 
him. (R. 158-177) 
The evidence before the lower court was undisputed that 
Respondent Dr. Moress acted as a "merchant" in respect to the 
selection, sale and distribution of Tegretol and Phenobarbital 
to Appellant Larry Reeves. Appellant's mother, Mrs. Alma Cook, 
testified that Dr. Moress prescribed and provided these drugs to 
Larry Reeves for the treatment of his seizure disorder. (Alma Cook 
Depo., pp. 58-59) 
Respondent Moress presented no evidence to the lower court 
to suggest that he did not select, sell and distribute Tegretol 
12 
and Phenobarbital to Appellant Larry Reeves, or to show that 
he was not negligent in the marketing, distribution and promotion 
of the drugs Tegretol and Phenobarbital to Appellant Larry 
Reeves as a "merchant." 
Respondent Moress' liability to Appellant Larry Reeves 
on his First through Fourth Causes of Action relating to products 
liability and breach of warranty, must be determined on 
standards applicable to "merchants", and not on the basis 
of "medical malpractice" standards strictly applicable to 
physicians. The Affidavit of Respondents' expert, Joel A. Thompson, 
M.D., relates solely to his opinions concerning Appellant Reeves' 
"medical malpractice" claims against Respondent Moress, and 
contains no facts, opinions, or the basis for the expression of 
any expert opinion by Dr. Thompson regarding the liability of 
Dr. Moress on Larry Reeves' claims against him as a "merchant", 
alleged in the First through Fourth Causes of Action in Appellant's 
Complaint. 
Based upon the foregoing, the lower court clearly abused its 
discretion in granting Respondent Moress summary judgment on 
Appellant Reeves' First through Fourth Causes of Action 
based on strict products liability and breach of express or 
implied warranties, and not "medical malpractice." 
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POINT III. THE EVIDENCE BEFORE THE LOWER COURT PRESENTED 
A GENUINE FACTUAL DISPUTE ON THE ISSUE OF 
WHETHER RESPONDENT MORESS HAD OBTAINED THE 
"INFORMED CONSENT" OF APPELLANT REEVES OR HIS 
PARENT TO HIS TREATMENT WITH THE DRUGS TEGRETOL 
AND/OR PHENOBARBITAL WHICH RENDERED SUMMARY 
JUDGMENT FOR RESPONDENT MORESS ON THIS ISSUE 
IMPROPER. 
In the Fifth and Sixth Causes of Action set forth in his 
Complaint, Appellant Larry Reeves seeks damages against 
Respondent Dr. Moress for failing to obtain his informed 
consent to treatment with Tegretol and/or Phenobarbital, as 
required pursuant to Utah Code Annotated, Sec. 78-14-5, 
as amended (1976). R. 12-16. 
Appellant Reeves' mother, Alma Cook, testified in her 
deposition that at the time Respondent Moress prescribed Tegretol 
and Phenobarbital for the treatment of Larry Reeves' seizure 
disorder, he never discussed these drugs or their side effects 
with them, and that he never provided them with any literature 
that explained the potential side effects of these drugs. (Depo. 
of Alma Cook, pp. 59-60) 
Respondent Moress presented no documents, testimony or 
affidavit in the lower court to contradict Mrs. Cook's testimony, 
and there is no record or document that shows that Dr. Moress 
ever did discuss any of the potentially severe and substantial 
side-effects of Tegretol and/or Phenobarbital, including the 
blistering skin disease actually suffered by Larry Reeves, 
14 
with Appellant Reeves or his mother. 
The Affidavit of Respondents' expert, Joel A. Thompson, 
M.D., does not address the issue of "informed consent" and 
contains no statement or opinion that Dr. Moress' failure to 
inform Larry Reeves and his mother of the potential severe and 
substantial side-effects of Tegretol and/or Phenobarbital did 
not constitute "malpractice", or the basis for any such opinion. 
There is no indication in Dr. Thompson's Affidavit that he even 
knew that Respondent Moress had not warned Appellant Reeves or his 
mother of the serious and substantial side-effects of the drugs 
in question. 
In addition, none of the opinions rendered by Dr. Thompson 
in his Affidavit are expressed in terms of "a reasonable medical 
certainty." (R. 162-164) 
In order to be entitled to summary judgment on the 
"informed consent" causes of action against him, Respondent 
Moress had the obligation to present expert medical testimony 
that he had no obligation to warn Larry Reeves or his mother of 
the side-effects of Tegretol and/or Phenobarbital, either because 
the risk of the side-effects experienced by Appellant Reeves 
were not "serious" or "substantial." Nixdorf v. Hicken, 612 
P.2d 348, 352 (Utah 1980); Jennings v. Stoker, 652 P.2d 912, 
914 (Utah 1982). 
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Respondents at least recognize the "burden" of a 
plaintiff to produce expert medical testimony regarding issues 
where the physician's compliance with the standard of care is 
in question. (Respondents' Br., p. 10) 
Having failed to adduce any expert medical testimony on 
the issue of "informed consent", Respondent Moress was not 
entitled to summary judgment on Appellant Reeves' Fifth and 
Sixth Causes of Action against him, and it was error for the 
lower court to grant it. 
POINT IV. THE LOWER COURT ABUSED ITS DISCRETION IN 
GRANTING RESPONDENTS' MOTIONS FOR SUMMARY 
JUDGMENT WITHOUT AFFORDING APPELLANT REEVES 
THE OPPORTUNITY FOR FURTHER DISCOVERY 
AS REQUESTED IN COUNSEL'S AFFIDAVIT FILED 
PURSUANT TO RULE 56(f), U.R.C.P. 
Respondents wrongly contend that the hearing on their Motions 
for Summary Judgment was postponed until June 2, 1986, to provide 
Appellant Reeves with the opportunity to file Affidavits in 
opposition to those submitted by Respondents' experts. (Respondents' 
Br., p.11) 
The hearing was postponed only because Appellant's counsel 
was already scheduled for hearings on May 19, 1986, the date originally 
assigned for hearing of Respondents' Motions. R. 189, paras. 4-5. 
Appellant Reeves's Motion for Further Discovery and 
Affidavit pursuant to Rule 56(f) filed on May 6, 1986, gave 
express notice to Respondents and the lower Court that Appellant 
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Reeves would not be able to file affidavits to counter those of 
Respondents* experts without the opportunity for additional 
discovery• Appellant's Motion For Further Discovery was also 
scheduled for hearing on the same date as Respondents' Motions 
For Summary Judgment. (R. 188-191) 
Respondents' alternative arguments to the effect that 
Appellant Reeves had done enough discovery, or that no further 
discovery was required, or that Appellant's counsel was dilatory 
in completing discovery, are without merit for the reasons 
reviewed in Appellant's Opening Br., pp. 2-8; 9-14, and did 
not justify the lower court in granting Respondents' Motions 
For Summary Judgment without permitting Appellant Reeves a 
reasonable opportunity to conduct further discovery. 
CONCLUSION 
The lower court abused its discretion in granting 
Respondents' Motions For Summary Judgment on all of Appellant 
Larry Reeves's claims against them, for the reasons that 
the evidence before the lower court did not entitle Respondents 
to summary judgments, or presented disputed issues of fact which 
should have been submitted to a jury, and because the lower 
court should have permitted Appellant Reeves the opportunity for 
additional discovery based upon the Affidavit of his counsel 
pursuant to Rule 56(f), U.R.C.P., prior to forever foreclosing 
Appellant Reeves the right to redress his substantial claims against 
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Respondents . 
Based upon the foregoing, Appellant Larry Ray Reeves 
respectfully requests this Court to reverse the lower court's 
grant of summary judgments for Respondents and permit this 
action to proceed to a trial on the merits. 
DATED and respectully submitted this 15th day of May, 1987 
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